Suppr超能文献

明尼苏达州奥姆斯特德县2000年至2010年罕见皮肤恶性肿瘤的发病率及临床特征

Incidence and Clinical Features of Rare Cutaneous Malignancies in Olmsted County, Minnesota, 2000 to 2010.

作者信息

Tolkachjov Stanislav N, Schmitt Adam R, Muzic John G, Weaver Amy L, Baum Christian L

机构信息

*Department of Dermatology, Mayo Clinic, Rochester, Minnesota;†Division of Biomedical Statistics and Informatics, Mayo Clinic Rochester, Minnesota;‡Division of Dermatologic Surgery, Mayo Clinic, Rochester, Minnesota.

出版信息

Dermatol Surg. 2017 Jan;43(1):116-124. doi: 10.1097/DSS.0000000000000936.

Abstract

BACKGROUND

The incidence of rare cutaneous malignancies is unknown. Current estimates of rare cutaneous malignancy incidences are based on broad epidemiologic data or single institution experiences, not population-based data.

OBJECTIVE

To determine the incidence of several rare nonmelanoma skin cancers.

MATERIALS AND METHODS

The authors conducted a retrospective chart review of a population-based cohort between the years 2000 and 2010. Residents of Olmsted County, Minnesota, who were diagnosed with a biopsy-proven nonmelanoma skin cancer-excluding basal cell carcinoma and squamous cell carcinoma-were included in this study. The primary outcome was tumor incidence. Additionally, the authors extracted patient demographics, tumor characteristics, treatment modalities, and outcomes.

RESULTS

The age-adjusted and sex-adjusted incidences per 100,000 persons of multiple rare cutaneous malignancies were: atypical fibroxanthoma (1.8), sebaceous carcinoma (0.8), dermatofibrosarcoma protuberans (0.4), microcystic adnexal carcinoma (0.7), eccrine carcinoma (0.4), eccrine porocarcinoma (0.2), and leiomyosarcoma (0.2).

CONCLUSION

The authors report population-based incidences and clinical characteristics for these rare cutaneous malignancies. The immune status and smoking status of patients and the treatment and outcomes of these tumors are reported. Additional studies in a broader population are needed to further define the epidemiology and outcomes of these malignancies.

摘要

背景

罕见皮肤恶性肿瘤的发病率尚不清楚。目前对罕见皮肤恶性肿瘤发病率的估计是基于广泛的流行病学数据或单一机构的经验,而非基于人群的数据。

目的

确定几种罕见的非黑色素瘤皮肤癌的发病率。

材料与方法

作者对2000年至2010年期间基于人群的队列进行了回顾性病历审查。明尼苏达州奥尔姆斯特德县被活检证实患有非黑色素瘤皮肤癌(不包括基底细胞癌和鳞状细胞癌)的居民纳入本研究。主要结局是肿瘤发病率。此外,作者提取了患者的人口统计学信息、肿瘤特征、治疗方式和结局。

结果

每10万人中多种罕见皮肤恶性肿瘤的年龄调整和性别调整发病率分别为:非典型纤维黄色瘤(1.8)、皮脂腺癌(0.8)、隆突性皮肤纤维肉瘤(0.4)、微囊性附属器癌(0.7)、汗腺癌(0.4)、汗腺导管癌(0.2)和平滑肌肉瘤(0.2)。

结论

作者报告了这些罕见皮肤恶性肿瘤基于人群的发病率和临床特征。报告了患者的免疫状态和吸烟状态以及这些肿瘤的治疗和结局。需要在更广泛的人群中进行进一步研究,以进一步明确这些恶性肿瘤的流行病学和结局。

相似文献

3
Adnexal skin tumors in Zaria, Nigeria.尼日利亚扎里亚的附件皮肤肿瘤
Ann Afr Med. 2008 Mar;7(1):6-10. doi: 10.4103/1596-3519.55691.
4
Nonmelanoma skin cancer.非黑色素瘤皮肤癌
Facial Plast Surg Clin North Am. 2013 Feb;21(1):43-53. doi: 10.1016/j.fsc.2012.10.003.
6
Uncommon cutaneous neoplasms of the head and neck.头颈部罕见皮肤肿瘤
Facial Plast Surg Clin North Am. 2012 Nov;20(4):483-91. doi: 10.1016/j.fsc.2012.08.002.
7
[Management of malignant adnexal neoplasms of the skin].[皮肤恶性附件肿瘤的管理]
Hautarzt. 2021 Jul;72(7):619-632. doi: 10.1007/s00105-021-04829-x. Epub 2021 Jun 17.

引用本文的文献

1
Eccrine Porocarcinoma: A Review of the Literature.小汗腺癌:文献综述
Diagnostics (Basel). 2023 Apr 16;13(8):1431. doi: 10.3390/diagnostics13081431.
3
Diagnosis and Management of Porocarcinoma.汗孔癌的诊断与管理
Cancers (Basel). 2022 Oct 25;14(21):5232. doi: 10.3390/cancers14215232.
4
7
Oral Capecitabine Achieves Response in Metastatic Eccrine Carcinoma.口服卡培他滨对转移性小汗腺癌有效。
Case Rep Oncol Med. 2018 Mar 1;2018:7127048. doi: 10.1155/2018/7127048. eCollection 2018.
8
Dermatofibrosarcoma Protuberans: Retrospective Single Center Analysis Over 16 Years.隆突性皮肤纤维肉瘤:16年单中心回顾性分析
Open Access Maced J Med Sci. 2018 Jan 10;6(1):35-37. doi: 10.3889/oamjms.2018.030. eCollection 2018 Jan 25.

本文引用的文献

5
Sebaceous carcinoma: review of the literature.皮脂腺癌:文献回顾。
Dermatol Surg. 2015 Jan;41(1):1-15. doi: 10.1097/DSS.0000000000000152.
6
Recurrent atypical fibroxanthoma with satellite metastasis.复发性非典型纤维黄色瘤伴卫星灶转移。
J Cutan Pathol. 2015 Jan;42(1):56-60. doi: 10.1111/cup.12447. Epub 2014 Dec 29.
8
Dermatofibrosarcoma protuberans, version 1.2014.隆突性皮肤纤维肉瘤,版本 1.2014。
J Natl Compr Canc Netw. 2014 Jun;12(6):863-8. doi: 10.6004/jnccn.2014.0081.
9
A case of metastatic dermatofibrosarcoma protuberans.一例转移性隆突性皮肤纤维肉瘤。
Dermatol Surg. 2014 Jun;40(6):708-9. doi: 10.1111/dsu.0000000000000005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验